The Latest News
New Study Shows ‘Forever Chemicals’ Linked to Testicular Cancer Tumor Growth
A new paper published by a team that includes several Cancer Center at Illinois (CCIL) researchers demonstrates a link between per- and polyfluoroalkyl substances (PFAS) exposure and growth of testicular germ cell tumors. PFAS chemicals, sometimes called forever...
Testicular Cancer Awareness Month: Research Team Working Toward New Options for Patients
Testicular cancer is a rare form of one of the world’s most devastating diseases. Most cases respond well to conventional treatments, but a team affiliated with the Cancer Center at Illinois (CCIL) has spent years working on ways to help patients who don’t have that...
The Tumor Engineering and Phenotyping (TEP) Facility Is Home to a New Nanoparticle Synthesizer
The Tumor Engineering and Phenotyping (TEP) facility, a Cancer Center at Illinois (CCIL) shared resource, is here to accelerate your discoveries with the addition of a new instrument for nanoparticle synthesis. The PreciGenome NanoGenerator™ Flex-M utilizes a...
2024 CCIL Seed Grant Program
The Cancer Center at Illinois is soliciting interdisciplinary team research proposals to initiate new collaborations and enhance existing collaborations among faculty.